에이전틱스(AGTX)는 PINK에 상장된 Healthcare · N/A 기업입니다. 현재가 $0.04 (+0.00%), 시가총액 $1.60M, 52주 범위 $0.02 ~ $0.07.
Agentix Corp., a clinical development stage company, focuses on the development and commercialization of novel therapeutics to treat metabolic diseases in the United States. It develops AGTX-2004, a peripherally-acting CB1 receptor antagonist that has demonstrated efficacy in animal models of obesity and type 2 diabetes mellitus; and AGTX-2003, a peripherally-acting CB1 receptor inverse agonist, which has demonstrated efficacy in animal models of obesity and non-alcoholic fatty liver diseases. The company has licensing agreement with National Health Research Institute and Research Triangle Institute. The company was formerly known as FairWind Energy, Inc.
에이전틱스의 재무제표, 목표주가, 기관투자자(13F) 보유 현황, 관련 뉴스는 XTS에서 실시간으로 확인할 수 있습니다.
에이전틱스의 현재 주가는 $0.04 (+0.00%)입니다. XTS에서 시세와 차트를 확인할 수 있습니다.
에이전틱스의 시가총액은 약 $1.60M입니다.
Agentix Corp., a clinical development stage company, focuses on the development and commercialization of novel therapeutics to treat metabolic diseases in the United States.